Regenerative Medicine Minnesota Announces 2016 Research Award Recipients
Regenerative Medicine Minnesota is a state supported initiative to advance Regenerative Medicine.
Mayo Clinic awardees include:
Dr. John C. Burnett, Jr, MD (Translational Research Grant) Novel Cell-Free Peptide Therapeutics for Cardiac Repair and Regeneration. Dr. Burnett's study will focus on the use of Mayo Clinic-engineered peptides in cardiac repair and regeneration.
Dr. Kimberly Holst, MD (Clinical Trial Grant) Phase I Study of Delivery of Autologous Bone Marrow Derived Mononuclear Cells to Myopathic Right Ventricle in Patients with Ebstein Anomaly During Surgical Intervention. This trial will deliver bone marrow-derived cells into the hearts of patients with Ebstein anomaly (EA), a malformed heart valve that doesn't properly close.
Dr. Nathan P. Staff, MD, PhD (Clinical Trial Grant) A Phase IIA Study Using Intrathecal Treatment of Autologous Adipose-Derived Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis. Clinical trial will assess safety and efficacy of mesenchymal stem cell spinal injections as a regenerative therapy for amyotrophic lateral sclerosis (ALS), an incurable condition that gradually degenerates nerve cells and reduces voluntary muscle function.